Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

Sarah Pogue(Biolog (United States)), David S. Wilson(Teva Pharmaceuticals (United States))
PLoS ONE
September 9, 2016
Cited by 59


Related Papers

No related papers found

Powered by citation graph analysis